Biotech Values

[jmkobers]

Also Dew, the oversize offering. Seems to be it's a good thing - demand was very high, but did result in slightly more dilution. However, spreading the upsized offering over multiple big name entities with real stakes seemed like a smart move to me. What's your take on it? Best(this is in beta testing, so plz bear with us), Joe